Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare?

Slipsager AB, Lauritzen MB, Buskov LK, Poulsen LØ.

Open source

DOI
10.2340/1651-226x.2026.45125
Published
2026-02-15
Container
Acta Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2340/1651-226x.2026.45125,
  title = {Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare?},
  author = {Slipsager AB and  Lauritzen MB and  Buskov LK and  Poulsen LØ.},
  year = {2026},
  journal = {Acta Oncol},
  doi = {10.2340/1651-226x.2026.45125},
  url = {https://doi.org/10.2340/1651-226x.2026.45125}
}

RIS

TY  - JOUR
TI  - Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare?
AU  - Slipsager AB
AU  -  Lauritzen MB
AU  -  Buskov LK
AU  -  Poulsen LØ.
PY  - 2026
JO  - Acta Oncol
DO  - 10.2340/1651-226x.2026.45125
UR  - https://doi.org/10.2340/1651-226x.2026.45125
ER  - 

APA

AB, S., MB, L., LK, B., & LØ., P. (2026). Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare?. Acta Oncol. https://doi.org/10.2340/1651-226x.2026.45125

Source records